Prof Dr. Gang Liu|Cancer|Best Researcher Award

Published on by Top Pharmaceutical

Prof Dr. Gang Liu|Cancer |Best Researcher Award

Prof Dr. Gang Liu atGansu Provincial Center for Disease Control and Prevention,China

PROFILE  

orcid

 

Early Academic Pursuits 🎓

Gang Liu embarked on his academic journey with a strong foundation in biological sciences, which laid the groundwork for his future contributions to radiobiology and immunology. From a young age, Liu demonstrated a deep curiosity about the impacts of radiation on human health, especially in relation to cancer screening and radiation therapy. His academic training was marked by a focus on understanding biological responses to radiation exposure, which ultimately shaped his career. He pursued higher education at prestigious institutions, honing his expertise in radiological sciences and immersing himself in research that would define his later work. His education not only provided him with technical knowledge but also equipped him with the analytical skills necessary to lead complex research projects.

Professional Endeavors 🏢

Upon completing his academic training, Liu began his professional career at the Gansu Provincial Center for Disease Control and Prevention, where he took on the role of a professor and researcher. Here, his work centered around radiobiology, immunology, tumor screening, and radiation protection in the context of radiation therapy. His research was not limited to theoretical study but extended to practical applications, particularly in developing noninvasive cancer screening techniques and advancing radiological protection standards. His work directly addressed critical health concerns, including the long-term effects of radiation on exposed populations and the improvement of safety protocols in radiation therapy. Through collaboration with other professionals in the field, Liu contributed to the development of innovative approaches to radiation protection, setting new benchmarks in both the medical and industrial applications of radiology.

Contributions and Research Focus 🔬

One of Gang Liu’s significant contributions to the scientific community was his revision of the 2011 IAEA Manual based on his findings from a radiological sensitivity and dose rate survey. This work, which was published in The FASEB Journal, a leading international publication, garnered attention for its insights into radiological sensitivity. The study was crucial for enhancing radiation safety and provided essential data for refining radiation protection guidelines. Liu also spearheaded research into chromosomal aberration analysis, a cutting-edge method for early cancer detection that avoids invasive procedures. This novel technique demonstrated the potential to transform how early-stage cancers are identified, making screening less stressful for patients and more accessible in clinical settings.

In addition, Liu’s work on the long-term medical effects of radiation exposure has been instrumental in understanding how radiation impacts health over time, particularly in individuals who have been overexposed to it. This research has far-reaching implications, not only for medical treatment and prevention strategies but also for policy development regarding radiation safety in various industries.

Accolades and Recognition 🏆

Liu’s impressive body of work has earned him several accolades and appointments to editorial boards. He is a respected editorial member of prestigious journals, including the Chinese Journal of Radiological Medicine and Protection, the International Journal of Radiological Medicine and Nuclear Medicine, and the Artificial Intelligence in Medical Imaging. His editorial roles are a testament to his expertise and leadership in the field, as he helps guide the dissemination of critical research findings to the global scientific community.

His membership in multiple professional organizations also highlights his influence. He is actively involved with the Chinese Medical Association Radiation Medicine and Protection Branch, the Chinese Health Supervision Association, and committees focusing on radiation disease diagnosis, treatment, and radiation protection equipment. Through these memberships, Liu contributes to shaping policies and practices that enhance radiation safety and improve public health outcomes.

Impact and Influence 🌍

Liu’s research has had a profound impact, particularly in advancing noninvasive cancer screening techniques. By focusing on chromosomal aberration analysis, his work has led to breakthroughs that improve early detection rates for cancers, which is vital for treatment success and patient survival. His contributions have not only influenced the scientific community but also had tangible effects on clinical practices and public health policies regarding radiation safety.

In addition to his direct research contributions, Liu’s collaborations with institutions such as the Institute of Radiological Medicine at the Chinese Academy of Medical Sciences have extended his influence. These collaborations foster knowledge exchange and contribute to the advancement of radiological medicine on both a national and international scale. His work is often cited in major scientific databases like SCI and Scopus, underlining its significance in the global scientific arena.

Legacy and Future Contributions 🧬

As a leader in the field of radiobiology, Gang Liu’s legacy is characterized by his commitment to improving public health through innovative research and practical applications. His ongoing projects continue to push the boundaries of what is known about radiation exposure, cancer screening, and radiation therapy. With a deep focus on radiation protection, his work remains crucial for both medical professionals and policymakers in enhancing safety standards.

Looking ahead, Liu is likely to focus on the integration of artificial intelligence (AI) into radiological research, as evidenced by his editorial involvement in AI-focused medical journals. This future direction holds promise for even more precise diagnostic tools and enhanced safety measures in radiation therapy. His dedication to research and collaboration ensures that he will continue to play a pivotal role in advancing the fields of radiobiology, immunology, and radiation protection.

Conclusion 🏅

Gang Liu’s journey from academic exploration to professional excellence is marked by significant contributions to radiobiology and radiation protection. His work in cancer screening, radiation sensitivity, and long-term health impacts of radiation exposure has left an indelible mark on the scientific community. With numerous editorial positions, professional memberships, and collaborative projects, Liu’s impact reaches far beyond the laboratory, influencing health policies and radiation safety standards worldwide. His future endeavors promise to further enhance global health outcomes, making him a distinguished figure in his field.

🎓Publication 

Topology optimization of a 120° bending high temperature superconducting photonic crystal waveguide

  • Authors   :Gang Liu; Yongpan Gao; Shuzhen Lu; Baonan Jia; Xiaoning Guan; Lihong Han; Pengfei Lu
  • Journal    :Physics
  • Year         :2024

Revision of cytogenetic dosimetry in the IAEA manual 2011 based on data about radio-sensitivity and dose-rate findings contributing

  • Authors   :Liu, Gang
  • Journal    :The FASEB Journal
  • Year         :2024

Study of Low-Dose Radiation Workers Ionizing Radiation Sensitivity Index and Radiation Dose-Effect Relationship

  • Authors   : Liu, Gang; Zhang, Rong; Li, Ye; Wu, Xiao Qin; Niu, Li Mei; Liu, Yin Yin; Zhang, Xue
  • Journal    : Health Physics
  • Year         :2022

Study of the occupational health risk of radon exposure in underground workers in a mine

  •  Authors   : Liu, Gang; Niu, Li Mei; Cao, Xia Bao; Liu, Yin Yin; Wu, Xiao Qin; Zhang, Xue; Zhang, Rong; Li, Ye
  • Journal    : Radiation Research and Applied Sciences
  • Year         :2022

Thyroid dose assessments due to inhalation of <SUP>131</SUP>I for nuclear medicine workers

  • Authors   : Liu, Gang; Li, Ye; Zhang, HanYu; Zhang, Xue; Liu, Yin Yin; Wu, Xiao Qin; Niu, Li Mei; Zhang, Rong
  • Journal    : Public Health
  • Year         :2022

Assoc Prof Dr. Ashok Behera|Pharmacy|Best Researcher Award

Published on by Top Pharmaceutical

Assoc Prof Dr. Ashok Behera|Pharmacy |Best Researcher Award

Assoc Prof Dr. Ashok Behera at DIT University,India

PROFILE  

orcid

Google scholar

Early Academic Pursuits 🎓

Dr. Behera’s academic journey laid a solid foundation for his career in medicinal chemistry. After completing his 10th standard from H.Katapali High School in Odisha with first division honors, he pursued his 12th Science from the Council of Higher Secondary Education (CHSE), Odisha, in 2000. His early interest in chemistry and biology was evident in his undergraduate studies, where he earned a B.Pharm degree from Biju Pattnaik University of Technology (BPUT), Odisha, in 2007, with a CGPA of 8.33/10, reflecting his outstanding academic performance in subjects like pharmaceutical chemistry and pharmacology.

His academic journey reached new heights when he secured admission to the National Institute of Pharmaceutical Education and Research (NIPER), Kolkata, for an M.S. (Pharm) in Medicinal Chemistry. During this time, he developed a deep interest in drug discovery, which culminated in his thesis titled “Synthesis of Biologically Active Medium Ring Heterocycles using Amino Acid as Precursors.” With a CGPA of 9.46/10 (89.60%), he proved his prowess in medicinal chemistry and drug action principles.

In 2014, Dr. Behera was awarded a Ph.D. in Pharmacy from Jadavpur University, supported by his work at the CSIR-Indian Institute of Chemical Biology (IICB). His doctoral thesis, titled “Synthesis of New Somatostatin Receptor Binding Radiolabeled Peptides: Physico-chemical and Biological Evaluation and Scintigraphic Studies,” explored innovative approaches in radiopharmaceutical development for cancer imaging, marking his entry into the specialized field of nuclear medicine.

Professional Endeavors and Research Focus 🔬

Dr. Behera’s professional career has been marked by both academic and research excellence. His career in academia began as an Assistant Professor at various prestigious institutions, including The M.S. University of Baroda and Himalayan Pharmacy Institute. His dedication to teaching and mentoring students was complemented by his extensive research work, particularly in the fields of peptide chemistry and targeted drug delivery systems.

One of the key areas of Dr. Behera’s research includes peptidomimetics and peptide conjugates as therapeutics. His work has focused on the development of receptor-specific drug delivery mechanisms, especially in the realm of anticancer drug discovery. His expertise in solid-phase peptide synthesis and stapled peptide synthesis has allowed him to contribute significantly to the synthesis and purification of novel peptides with therapeutic potential.

His research further delves into computer-aided drug design (CADD), where he employs virtual docking techniques using tools like AutoDock Vina and Chimera. He has also demonstrated proficiency in various analytical techniques, including FT-IR, NMR, and Mass Spectrometry, making him a versatile figure in both synthetic and analytical chemistry.

Contributions to Science and Innovation 🌟

Dr. Behera has developed a reputation as a thought leader in medicinal chemistry, particularly through his research on radiolabeled peptides for cancer imaging. His groundbreaking work in synthesizing radiolabeled anticancer drugs for nuclear imaging has opened new avenues for targeted therapies in oncology. He has conducted extensive studies on in vitro assays, radioligand binding assays, and in vivo pharmacokinetic studies, pushing the boundaries of radiopharmaceutical development.

His contribution to biological studies is equally noteworthy, having worked on cell line assays, mechanistic studies, and tumor imaging via SPECT gamma cameras. His work in this domain aims to improve the precision of cancer diagnosis and treatment, combining both chemistry and biology to create innovative solutions.

Accolades and Recognition 🏆

Dr. Behera’s excellence in research and teaching has been recognized with numerous awards and fellowships. He was awarded the Young Researcher Award in 2010 by the Saha Institute of Nuclear Physics in collaboration with the International Atomic Energy Agency (IAEA). He has also won multiple awards for oral and poster presentations at national and international conferences, including the Best E-poster presentation at the 24th Annual Convention of the Association of Pharmaceutical Teachers of India (APTI) in 2019.

In addition to his awards, Dr. Behera is an active member of prestigious organizations like the Royal Society of Chemistry (MRSC) and serves as a mentor for the CSIR Summer Research Training Program.

Impact and Influence 🌍

Dr. Behera’s impact extends beyond his research and teaching. As a mentor, he has guided several students through complex research projects, helping them navigate the intricacies of medicinal chemistry and drug design. His involvement in interdisciplinary projects, such as the development of receptor-specific targeted drugs and nuclear imaging techniques, has made a lasting impression on the scientific community.

His work is frequently cited in scientific literature, as evidenced by his strong presence on platforms like Google Scholar, ResearchGate, and Publons. His contributions have influenced both academic research and practical applications in the pharmaceutical industry, particularly in cancer therapeutics and imaging.

Legacy and Future Contributions 🌱

As Dr. Behera continues his journey in academia and research, his legacy will be defined by his relentless pursuit of innovation in medicinal chemistry. His work on peptide therapeutics, drug delivery systems, and nuclear imaging is poised to influence future generations of researchers and professionals in the pharmaceutical sciences.

With ongoing research in radiopharmaceutical development and a growing focus on bio-conjugation techniques, Dr. Behera’s future contributions will likely address some of the most pressing challenges in modern medicine, particularly in cancer treatment. His dedication to both education and research ensures that his legacy will inspire innovation and discovery for years to come.

🎓Publication 

Mitochondrial dysfunction and oxidative stress in Alzheimer’s disease, and Parkinson’s disease, Huntington’s disease and amyotrophic lateral sclerosis-an updated review

  • Authors   :Taha Alqahtani, Sharada L Deore, Anjali A Kide, Bhavana A Shende, Ritika Sharma, Rita Dadarao Chakole, Lalita S Nemade, Nikita Kishor Kale, Sudarshana Borah, Savita Shrikant Deokar, Ashok Behera, Divya Dhawal Bhandari, Nikita Gaikwad, Abul Kalam Azad, Arabinda Ghosh
  • Journal    :Mitochondrion
  • Year         :2023

Copper-Catalyzed Electrophilic Ortho C(sp2)–H Amination of Aryl Amines: Dramatic Reactivity of Bicyclic System

  • Authors   :Hasina Mamataj Begam, Rajarshee Choudhury, Ashok Behera, Ranjan Jana
  • Journal    :Organic letters
  • Year         :2019

Synthesis, radiolabeling, and preclinical evaluation of a new octreotide analog for somatostatin receptor‐positive tumor scintigraphy

  • Authors   :Kakali De, Arijit Bhowmik, Ashok Behera, Indranil Banerjee, Mrinal Kanti Ghosh, Mridula Misra
  • Journal    :Journal of Peptide Science
  • Year         :2012

Synthesis, radiolabelling and biodistribution of HYNIC-Tyr 3 octreotide: a somatostatin receptor positive tumour imaging agent

  • Authors   : Ashok Behera, Kakali De, Susmita Chandra, Sankha Chattopadhyay, Mridula Misra
  • Journal    :journal of Radioanalytical and Nuclear Chemistry
  • Year         :2011

Synthesis, characterization, conformational analysis of a cyclic conjugated octreotate peptide and biological evaluation of 99mTc-HYNIC-His3-Octreotate as novel …

  • Authors   : Ashok Behera, Indranil Banerjee, Kakali De, Rudra Narayan Munda, Sankha Chattopadhayay, Amalesh Samanta, Bharat Sarkar, Santanu Ganguly, Mridula Misra
  • Journal    :Amino Acids
  • Year         :2013

Prof. Rasha Azzam|Drug Discovery and Development|Best Researcher Award

Published on by Top Pharmaceutical

Prof. Rasha Azzam|Drug Discovery and Development |Best Researcher Award

Prof. Rasha Azzam at Helwan University,Egypt

PROFILE  

orcid

Early Academic Pursuits 🎓

Prof. Rasha A. Azzam’s academic journey began with her outstanding performance in chemistry at Helwan University, Egypt, where she graduated with a Bachelor of Science (B.Sc.) in Chemistry in 1993. Her excellence in academia was recognized early on, as she graduated with class honors and was placed on the Dean’s List. Driven by her passion for organic chemistry, she pursued a Master of Science (M.Sc.) degree in Organic Chemistry at Helwan University, completing it in 1996. Her academic curiosity and dedication led her to further her studies internationally, earning a prestigious Ph.D. in Organic Chemistry in 2003 from the Catholic University of Leuven in Belgium. Her diverse educational background laid the foundation for a career defined by groundbreaking research and academic excellence.

Professional Endeavors 🧑‍🔬

Prof. Azzam’s professional career spans over two decades of teaching, research, and leadership in various prestigious academic institutions across the globe. She is currently a Professor of Organic Chemistry at the Faculty of Science, Helwan University, where she has been contributing since 2021. Prior to this, she held the position of Associate Professor of Organic Chemistry at the same institution from 2016 to 2021, demonstrating her upward trajectory in academia.

Her teaching and research influence extended beyond Egypt. She has held positions as an Associate Professor at Taibah University in Saudi Arabia, Nigerian Turkish Nile University in Nigeria, and the American University in Nigeria, where she was a co-founder of the Petroleum Chemistry Program. Additionally, she has served as a Visiting Professor at Virginia Commonwealth University in 2024, further showcasing her international academic reach.

Contributions and Research Focus 🔬

Prof. Azzam’s research focuses on organic and medicinal chemistry, with a particular emphasis on green synthesis, nanomaterials, and antiviral agents. One of her key research interests is the development of new methods for synthesizing compounds with potential anticancer and antimicrobial properties. Her recent project, “Synthesis of new sulfa derivatives under ultrasonic irradiation as potential anticancer/antimicrobial agents,” funded by Helwan University in 2021, highlights her innovative approach to organic synthesis.

Prof. Azzam’s work also explores environmentally friendly technologies, as demonstrated by her research on “green technology based on nanoporous biodegradable polymeric membranes” for wastewater treatment, funded by the Academy of Scientific Research Technology (ASRT). She has also conducted pioneering work on nanomaterials and their applications in industrial processes, such as her research on thermoplastic elastomers based on petrochemicals and the development of anti-COVID-19 agents incorporated into nanofibrous mats.

Her research output is extensive, and she has presented several projects on global platforms, including her work on antiviral therapeutic agents and nanomaterials. Her research contributions are shaping the future of organic chemistry, particularly in the domains of green chemistry and medical applications.

Accolades and Recognition 🏆

Prof. Azzam’s excellence in research and community service has been recognized through numerous awards and honors. In 2023, she received the prestigious Prince Mohammed Bin Fahd Scientific Award for her contributions to scientific production that serves community development within the framework of sustainable development goals. In the same year, she was honored with Helwan University’s Outstanding Scientific Achievement Award in Basic and Applied Sciences.

She has also been recognized for her mentoring and supervision of students, receiving Best Master Thesis Awards for two of her master’s students, Rasha Essam (2020) and Heba Elboshi (2023). Her commitment to advancing research was further acknowledged when she received the Research Excellence Awards for her students, Rokia Ramadan (2019) and Rasha Essam (2020). Additionally, Prof. Azzam was awarded a Silver Medal from the Academy of Scientific Research Technology (ASRT) in 2018 for her outstanding contributions to science.

Her impact extends internationally, with her receiving the Outstanding Faculty Member Award from the American University in Nigeria in 2007, and a research scholarship from the Catholic University of Leuven in 2001.

Impact and Influence 🌍

Prof. Azzam’s influence is felt not only through her research but also through her active participation in the scientific community. She serves as a Review Editor for Organic Chemistry on the Editorial Board of Frontiers in Chemistry and as an editor for the Journal of Chemistry and The Scientific World Journal, both published by Hindawi. She is also a grant evaluator for the Fulbright Binational Scholarship Program, where she helps assess the next generation of academic leaders.

Her commitment to education and community service is reflected in her involvement in organizing training workshops for high school teachers and instructing lab sessions for the AUN Community School. Prof. Azzam is also a member of the Egyptian Society for Basic Sciences, where she contributes to the development of the scientific community in Egypt.

Legacy and Future Contributions 🌟

Prof. Rasha A. Azzam’s legacy is built on her unwavering dedication to advancing organic chemistry, fostering academic excellence, and mentoring the next generation of scientists. Her research has laid the groundwork for significant developments in green chemistry, nanomaterials, and medicinal chemistry. With her continued focus on innovative solutions for pressing global challenges, such as wastewater treatment and the development of antiviral agents, she is poised to make even more impactful contributions in the years to come.

🎓Publication 

In the pursuit of novel therapeutic agents: synthesis, anticancer evaluation, and physicochemical insights of novel pyrimidine-based 2-aminobenzothiazole derivatives

  • Authors   :Toka I. Ismail; Nashwa El-Khazragy; Rasha A. Azzam
  • Journal    :RSC Advances
  • Year         :2024

Novel High-Performance Functionalized and Grafted Bio-Based Chitosan Adsorbents for the Efficient and Selective Removal of Toxic Heavy Metals from Contaminated Water

  • Authors   :Mohammad Monir; Rasha E. Elsayed; Rasha Azzam; Tarek M. Madkour
  • Journal    :Polymers
  • Year         :2024

Crystal structure of 4-(benzo[d]thiazol-2-yl)-1,2-dimethyl-1H-pyrazol-3(2H)-one

  • Authors   :Heba A. Elboshi; Rasha A. Azzam; Galal H. Elgemeie; Peter G. Jones
  • Journal    :Acta Crystallographica Section E Crystallographic Communications
  • Year         :2024

Synthesis of New Guanidine Benzothiazole Derivative and Its Application as Eco-Friendly Corrosion Inhibitor

  • Authors   : Abdel-karim, Amal M.; Azzam, Rasha A.; Shehata, Omnia S.; Adly, Mohamed A.; El-Shamy, Omnia A. A.; El-Mahdy, Gamal A.
  • Journal    :Chemistry
  • Year         :2023

Crystal structure of 2-{[5-(methylsulfanyl)-4-phenyl-4H-1,2,4-triazol-3-yl]methyl}benzo[d]thiazole

  • Authors   : Rasha A. Azzam; Galal H. Elgemeie; Heba A. Elboshi; Peter G. Jones
  • Journal    :Crystallographica Section E Crystallographic Communications
  • Year         :2023

Dr. Marc Bender|Immunotherapy |Best Researcher Award

Published on by Top Pharmaceutical

Dr. Marc Bender|Pharmaceutical Chemistry |Best Researcher Award|

Dr. Marc Bender at abriz University of Medical Sciences, Iran

PROFILE  

orcid

Early Academic Pursuits 📚

Marc Bender’s academic journey began with a strong foundation in molecular biology, earning a (link unavailable) and (link unavailable) from Universität Hamburg. He furthered his expertise by pursuing a doctorate in skin cancer research at the department of dermatology, Elbe Klinikum Buxtehude. His thesis focused on elucidating molecular mechanisms, particularly epigenetic regulation via miRNAs, involved in tumor progression of cutaneous squamous cell carcinoma.

Professional Endeavors 💼

As a data scientist, Marc contributed to the European melanoma registry (EUMelaReg), evaluating retrospective data for real-world clinical trials. This experience deepened his understanding of melanoma and immunotherapy, and he developed skills in statistical methods and programming. His professional endeavors have been marked by a commitment to advancing cancer research and treatment.

Contributions and Research Focus 🔬

Marc’s research focus encompasses various aspects of skin cancer, including:

– Investigating effects of combined UVA, UVB, visible light, and infrared radiation on human skin cells (KAUVIR)
– Examining the influence of UVA and UVB irradiation on human dermal stem cells (UV-DHDS)
– Comparing treatments for melanoma, including anti-PD1 monotherapy and BRAF/MEK inhibitor treatment (PDSeq and EMRSeq)
– Analyzing immune checkpoint inhibitor maintenance treatment after achieving a partial or complete response (EUMelaReg)

Accolades and Recognition 🏆

Marc’s work has been recognized through publications in esteemed journals, including:

– Journal of Cancer Research and Clinical Oncology
– Journal of Photochemistry and Photobiology B Biology
– Cancers (MDPI)
– Journal of Clinical Oncology (conference paper)
– Annals of Oncology (conference paper)

Impact and Influence 🌟

Marc’s research has contributed significantly to the understanding of skin cancer mechanisms and treatment options. His work has:

– Advanced knowledge of miRNA expression and its association with tumor progression
– Investigated treatment adherence in patients with stage III melanoma
– Compared outcomes of different treatment approaches for metastatic melanoma

Legacy and Future Contributions 🌱

As a dedicated researcher, Marc continues to contribute to the field of skin cancer research. His future endeavors will likely focus on:

– Furthering understanding of molecular mechanisms in skin cancer
– Developing innovative treatment approaches
– Collaborating with international researchers to advance cancer research

Marc’s legacy will be marked by his commitment to advancing cancer research, improving treatment options, and enhancing patient outcomes. His work will continue to influence the scientific community, inspiring future generations of researchers.

🎓Publication 

Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany

  • Authors   : Marc Bender
  • Journal    :Cancers
  • Year         :2022

UVB damage response of dermal stem cells as melanocyte precursors compared to keratinocytes, melanocytes, and fibroblasts from human foreskin

  • Authors   :Marc Bender
  • Journal    :Photochemistry and Photobiology B: Biology
  • Year         :2021

UV-type specific alteration of miRNA expression and its association with tumor progression and metastasis in SCC cell lines

  • Authors   : Marc Bender
  • Journal    :Cancer Research and Clinical Oncologyy
  • Year         :2020

 

Prof Dr. Ali Shayanfar|Pharmaceutical Chemistry |Best Researcher Award

Published on by Top Pharmaceutical

Prof Dr. Ali Shayanfar|Pharmaceutical Chemistry |Best Researcher Award|

Prof Dr. Ali Shayanfar at abriz University of Medical Sciences, Iran

PROFILE  

Google scholar

Early Academic Pursuits 🎓

Shayan Fara began his academic journey at the Faculty of Pharmacy, Tabriz University of Medical Sciences, where he earned his Pharm.D. from 2003 to 2009. During these formative years, he developed a strong foundation in pharmaceutical sciences, laying the groundwork for his future career. His passion for pharmaceutical chemistry drove him to pursue a Ph.D. in the same field at Tabriz University of Medical Sciences from 2009 to 2013. His doctoral research focused on the solid-state and solution chemistry of drugs, an area that would later become a central theme of his research.

Professional Endeavors and Career Growth 🏢

After completing his Ph.D., Dr. Fara joined the Faculty of Pharmacy at Tabriz University of Medical Sciences as an Assistant Professor of Pharmaceutical Chemistry in 2014. His dedication to teaching and research led to a steady rise in his academic career. By 2018, he had been promoted to Associate Professor, and in 2023, he reached the pinnacle of his academic career by becoming a full Professor of Pharmaceutical Chemistry.

Dr. Fara’s professional endeavors extend beyond teaching. He has held several key administrative positions, including serving as the Secretary and Research Secretary of the Student Research Committee at Tabriz University of Medical Sciences. His leadership skills and commitment to research were further recognized when he became the Head of the Student Research Committee from 2018 to 2020.

Contributions and Research Focus 🧪

Dr. Fara’s research interests are diverse and impactful, focusing on the solid-state and solution chemistry of drugs, pharmaceutical and biomedical analysis, and modeling in pharmaceutical sciences. He has made significant contributions to understanding the physical and chemical properties of drugs in both solid and solution states. His work in this area has implications for drug formulation, stability, and bioavailability, making it crucial for the development of more effective pharmaceutical products.

His expertise extends to various analytical techniques, including UV-Vis spectrophotometry, HPLC, spectrofluorimetry, FT-IR, DSC, and PXRD. He has also conducted extensive research in chemometrics, molecular modeling, QSAR and QSPR studies, solubility and dissolution rate determination techniques, and crystallization of drugs. His technical prowess in these areas has enabled him to contribute to the advancement of pharmaceutical sciences, both in theory and practice.

Accolades and Recognition 🏆

Throughout his career, Dr. Fara has received numerous accolades and recognition for his contributions to pharmaceutical sciences. His role as an editor in several prestigious journals, including being the Editor-in-Chief of the Pharmaceutical Sciences Journal since 2020, highlights his influence in the field. He has also served as an Associate Editor for the Pharmaceutical Sciences Journal from 2014 to 2020 and for the Directory of Open Access Journals (DOAJ) from 2017 to 2018.

His editorial roles, combined with his contributions to research, have earned him a place on the editorial boards of several high-impact journals, including Pharmaceutical Sciences and ImmunoAnalysis. His involvement with these journals not only showcases his expertise but also his commitment to advancing the quality and accessibility of scientific knowledge.

Impact and Influence 🌍

Dr. Fara’s impact on the field of pharmaceutical sciences is profound. His research has influenced the development of new analytical methods and drug formulations, contributing to the broader field of pharmaceutical chemistry. His work in modeling and chemometrics has provided valuable insights into the relationship between drug properties and their therapeutic efficacy.

In addition to his research contributions, Dr. Fara has been instrumental in mentoring the next generation of pharmaceutical scientists. His teaching experience spans various subjects, including Analytical Chemistry, Medicinal Chemistry, Instrumental Analysis, General Chemistry, Medical Information Systems, Research Methods, Endnote Software, and Ethics in Publication. His dedication to education ensures that his influence will extend far beyond his direct contributions to research.

Legacy and Future Contributions 🌟

As Dr. Fara continues his career as a Professor of Pharmaceutical Chemistry, his legacy is already being built through his research, teaching, and editorial work. His ongoing contributions to the field, particularly in the areas of drug analysis and modeling, will continue to shape the future of pharmaceutical sciences. His commitment to excellence in research and education, combined with his leadership in various academic and editorial roles, ensures that his impact will be felt for years to come.

🎓Publication 

Solubility of carvedilol in ethanol+ propylene glycol mixtures at various temperatures

  • Authors   :Sahel Vahdati, Ali Shayanfar, Jalal Hanaee, Fleming Martínez, William E Acree Jr, Abolghasem JouybanA et al...
  • Journal    :Industrial & Engineering Chemistry Research
  • Year         :2013

Review of pharmaceutical applications of N-methyl-2-pyrrolidone

  • Authors   :Abolghasem Jouyban, Mohammad Amin Abolghasemi Fakhree, Ali Shayanfar
  • Journal    :Journal of Pharmacy & Pharmaceutical Sciences
  • Year         :2010

Deep eutectic solvents for pharmaceutical formulation and drug delivery applications

  • Authors   :Shahram Emami, Ali Shayanfar
  • Journal    :Pharmaceutical development and technology
  • Year         :2020

Effect of choline chloride/ethylene glycol or glycerol as deep eutectic solvents on the solubility and thermodynamic properties of acetaminophen

  • Authors   : Hemayat Shekaari, Mohammed Taghi Zafarani-Moattar, Ali Shayanfar, Masumeh Mokhtarpour
  • Journal    :Journal of Molecular Liquids
  • Year         :2018

Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy

  • Authors   :Ommoleila Molavi, Farzaneh Narimani, Farshid Asiaee, Simin Sharifi, Vahideh Tarhriz, Ali Shayanfar, Mohammadsaied Hejazi, Raymond Lai
  • Journal    : Pharmaceutical biology
  • Year         :2017

Assoc Prof Dr. Mohammed Saddik |Formulation Science |Best Researcher Award

Published on by Top Pharmaceutical

Assoc Prof Dr. Mohammed Saddik|Formulation Science |Best Researcher Award|

Assoc Prof Dr. Mohammed Saddik atFaculty of Pharmacy, Sohag University, Egypt

PROFILE  

 

Orcid

Early Academic Pursuits 🎓

Mohammed Sherif Saddik Ibrahim began his academic journey with a strong foundation in pharmaceutical sciences. He earned his Bachelor of Pharmaceutical Sciences from the Faculty of Pharmacy, Assiut University, Egypt, on July 22, 2006. His dedication to the field was evident early on, as he quickly advanced to pursue postgraduate studies. By July 24, 2011, he had obtained his Master’s degree in Pharmaceutical Sciences, specializing in pharmaceutics. His master’s thesis, titled “Formulation and Clinical Evaluation of Some Topical Pharmaceutical Dosage Forms of Phenytoin,” highlighted his interest in the clinical applications of pharmaceuticals. Not stopping there, Mohammed continued his academic pursuits, earning a Doctor of Pharmaceutical Sciences (Ph.D.) in Pharmaceutics from Assiut University on January 24, 2017. His doctoral research focused on the “Formulation and Clinical Evaluation of Some Topical Pharmaceutical Dosage Forms of Methylene Blue for Photodynamic Therapy,” showcasing his commitment to innovative therapeutic solutions.

Professional Endeavors 🧑‍🏫

Dr. Mohammed Sherif Saddik Ibrahim’s professional career is marked by his continuous advancement in academia and clinical practice. He began as a Pharmacist at Al-Azhar University Hospital, Faculty of Medicine, Assiut University, where he worked from July 24, 2007, to October 11, 2014. This role allowed him to gain practical experience in the pharmaceutical field, which he later integrated into his teaching and research.

In 2014, Mohammed transitioned to an academic role at Sohag University, Egypt, where he served as an Assistant Lecturer of Pharmaceutics and Clinical Pharmacy until February 26, 2017. Following his Ph.D., he was promoted to Lecturer in the same department, a position he held until June 27, 2022. His excellence in teaching and research led to his appointment as an Associate Professor of Pharmaceutics and Clinical Pharmacy at Sohag University on June 29, 2022, where he continues to contribute to the field. Additionally, since September 13, 2022, Mohammed has been coordinating the Clinical Pharmacy Program at Sohag University, further cementing his role as a leader in pharmacy education.

Contributions and Research Focus 💡

Dr. Mohammed Sherif Saddik Ibrahim’s research is centered around the formulation and clinical evaluation of pharmaceutical dosage forms. His work has significant implications for enhancing the therapeutic efficacy of drugs and improving patient outcomes. One of his notable research contributions includes the development of topical pharmaceutical dosage forms for photodynamic therapy, specifically using methylene blue. This research is particularly important for its potential in treating various skin conditions and diseases through non-invasive methods.

Mohammed’s innovative approach is also evident in his work on drug delivery systems. He has supervised multiple postgraduate students, guiding them in research that explores novel drug formulations and delivery methods. His expertise in handling lab animals and conducting clinical studies further supports his research goals, particularly in designing dosage forms that are both effective and patient-friendly.

Accolades and Recognition 🏆

Throughout his career, Dr. Mohammed Sherif Saddik Ibrahim has received recognition for his contributions to pharmaceutical sciences. His work has led to several patents, including those for sulfasalazine-loaded zinc oxide nanoparticles for the treatment of ulcerative colitis (US11730759B1) and a polymeric clotrimazole biofilm for the treatment of otomycosis (US11844781B1). These patents reflect his innovative thinking and commitment to developing new therapeutic solutions.

His academic contributions have also been recognized through his participation in significant conferences. Notably, he presented at the NUB 2nd Conference of Scientific Research in Pharmacy Future Insight at the Faculty of Pharmacy, Nahda University, in March 2019, and the 1st Conference of Pharmaceutical Sciences at Badr University in Cairo, held online in November 2021. These platforms allowed him to share his research findings with the broader scientific community and gain insights into the latest developments in pharmaceutical sciences.

Impact and Influence 🌍

Dr. Mohammed Sherif Saddik Ibrahim’s impact on the field of pharmaceutics extends beyond his research. As an educator, he has taught a wide range of courses at Sohag University, including Pharmaceutics, Physical Pharmacy, Community Pharmacy, Controlled Drug Delivery, and Pharmaceutical Legislations & Regulatory Affairs. His teaching not only imparts knowledge but also inspires the next generation of pharmacists and researchers. Mohammed’s role as a coordinator of the Clinical Pharmacy Program at Sohag University further amplifies his influence, as he shapes the curriculum and ensures that students receive a comprehensive and up-to-date education.

His contributions to research have also had a tangible impact on patient care. The dosage forms and drug delivery systems he has developed have the potential to improve the treatment of various conditions, from skin diseases to chronic illnesses like ulcerative colitis. By focusing on patient-centered research, Mohammed’s work is helping to bridge the gap between laboratory research and clinical practice, ultimately benefiting patients in Egypt and beyond.

Legacy and Future Contributions 🚀

As a progressive professional with a strong research background, Dr. Mohammed Sherif Saddik Ibrahim is poised to continue making significant contributions to the field of pharmaceutical sciences. His commitment to education and research, particularly in the area of drug delivery systems, positions him as a leader in the field. Looking ahead, Mohammed aims to further explore the green synthesis of nanomaterials and their application in drug delivery. His goal is to develop innovative pharmaceutical dosage forms that are not only effective but also environmentally sustainable.

Mohammed’s vision for the future includes expanding his research to address emerging medical challenges, such as diabetes and leukemia. With two patents already in progress for treatments in these areas, he is actively working towards solutions that could have a profound impact on global health. His determination to identify innovative approaches and improve medical outcomes drives his research and teaching efforts.

Conclusion 🌟

Dr. Mohammed Sherif Saddik Ibrahim’s career is a testament to his dedication to advancing pharmaceutical sciences. From his early academic pursuits to his current role as an Associate Professor and researcher, he has consistently sought to improve drug delivery systems and therapeutic efficacy. His contributions to education, research, and patient care have left a lasting impact, and his future work promises to bring even more innovative solutions to the field. As he continues to explore new frontiers in pharmaceutics, Mohammed’s legacy as a visionary educator and researcher will undoubtedly grow.

🎓Publication 

Formulation and evaluation of azithromycin-loaded silver nanoparticles for the treatment of infected wounds.

  • Authors   :Saddik MS; Al-Hakkani MF; Abu-Dief AM; Mohamed MS; Al-Fattah IA; Mahmoud Makki; El-Mokhtar MA; Marwa A. Sabet; Amin MS; Ahmed HA et al...
  • Journal    :pharmaceutics
  • Year         :2024

Characterization and Bio-Evaluation of the Synergistic Effect of Simvastatin and Folic Acid as Wound Dressings on the Healing Process

  • Authors   : Mahmoud A. Hashem; Badriyah S. Alotaibi; Mahmoud M.A. Elsayed; Manal E. Alosaimi; Amal K. Hussein; Maram Abduljabbar; Kyung-Tae Lee; Hamdy Abdelkader; Mohamed A. El-Mokhtar ; Ahmed Hassan et al.
  • Journal    :Pharmaceutics
  • Year         :2023

Synthesis, Physicochemical Characterization using a Facile Validated HPLC Quantitation Analysis Method of 4-Chloro-phenylcarbamoyl-methyl Ciprofloxacin and Its Biological Investigations

  • Authors   :Mostafa F. Al-Hakkani; Nourhan Ahmed; Alaa A. Abbas; Mohammad H. A. Hassan; Hossameldin A. Aziz; Ali M. Elshamsy; Hazim O. Khalifa; Mohamed A. Abdelshakour; Mohammed S. Saddik; Mahmoud M. A. Elsayed et al.
  • Journal    :Molecular Sciences
  • Year         :2023

Development of Novel Nano-Sized Imine Complexes Using Coriandrum sativum Extract: Structural Elucidation, Non-Isothermal Kinetic Study, Theoretical Investigation and Pharmaceutical Applications

  • Authors   : Shimaa Hosny; Randa F. Abd El-Baki; Zeinab H. Abd El-Wahab; Gamal A. Gouda; Mohammed S. Saddik; Ateyatallah Aljuhani; Ahmed M. Abu-Dief.
  • Journal    :Molecular Sciences
  • Year         :2023

In vitro and in vivo synergistic wound healing and anti-methicillin-resistant Staphylococcus aureus (MRSA) evaluation of liquorice-decorated silver nanoparticles

  • Authors   :Hamdoon Mohammed; Mohammed A. Amin; Gamal Zayed; Yassar Hassan; Mohamed El-Mokhtar; Mohammed S. Saddik..
  • Journal    : Antibiotics
  • Year         :2023

Prof. Anca Oana Hermenean |Pharmacology |Best Innovation Award

Published on by Top Pharmaceutical

Prof. Anca Oana Hermenean|Pharmacology |Best Innovation Award|

Prof. Anca Oana Hermenean at Vasile Goldis Western University of Arad, Romania

PROFILE  

scopus

Orcid

Early Academic Pursuits 📚

Prof. Dr. Anca Hermenean began her academic journey at Babes-Bolyai University of Cluj-Napoca, Romania, where she earned her Bachelor’s degree in Biology from 1989 to 1994. This foundational education set the stage for her extensive career in biochemistry and molecular biology. Her academic prowess continued to shine as she pursued a PhD in Biology from 1997 to 2003, focusing on electron microscopy, histopathology, and immunohistochemistry. This period of intense study was marked by rigorous research and a commitment to understanding the microscopic and molecular mechanisms underlying various biological processes.

Professional Endeavors 🏛️

Prof. Hermenean’s professional career is distinguished by her roles in academia and research management. Since 2010, she has served as a Professor at the Faculty of Medicine, Vasile Goldis Western University of Arad (VGWU), where she has made significant contributions to the fields of histology and cell biology. Her expertise in these areas is evidenced by her ongoing research and teaching responsibilities.

In 2016, Prof. Hermenean was appointed Director of the VGWU Doctoral Studies Council, a role in which she has overseen the management and strategic development of doctoral programs in Medicine and Biology. Her leadership extended further in 2017 when she joined the Faculty of Engineering in Foreign Languages at Politehnica University of Bucharest, contributing to the Master Program in Biomaterials for Tissue Engineering. She has taught various courses related to cell and tissue biology, tissue regeneration, and debilitating diseases of tissue.

In 2020, Prof. Hermenean became the Director of the Life Science Institute and Principal Investigator at the Institute of Life Sciences, VGWU. Here, she manages research projects and oversees activities in microscopy labs and the animal facility, reflecting her deep engagement in both research and administration.

Contributions and Research Focus 🔬

Prof. Hermenean’s research contributions are broad and impactful, focusing on several key areas:

  1. Histology and Histopathology: Her work in these fields explores the microscopic structure of tissues and the pathological changes associated with various diseases. This includes significant contributions to understanding how cellular and tissular alterations can affect health.
  2. Phytomedicine: Prof. Hermenean has researched the modulation of signal transduction pathways by phytochemicals, their molecular regulation of anti-inflammatory and anti-fibrotic responses, and their interactions with drugs and chemicals.
  3. Nanobiotechnology: She has been involved in the characterization of bio-interfaces and in vivo biocompatibility studies of nanomaterials. Her work includes assessing the interactions between nanomedicines and biological systems, as well as evaluating structural and ultrastructural toxicological effects.
  4. Regenerative Medicine: Prof. Hermenean’s research also covers tissue repair and regeneration pathways, focusing on molecular signals, growth factors, and the mechanisms of tissue regeneration.

Accolades and Recognition 🏆

Prof. Hermenean’s work has garnered significant recognition within the scientific community. She holds a habilitation in Biology, a postdoctoral qualification that allows her to supervise PhD candidates. Her research has led to numerous publications in peer-reviewed journals, with an H-index of 30 on Scopus and 34 on Google Scholar. Additionally, she has been awarded several patents for her innovations in pharmaceutical compositions and drug delivery systems, underscoring her contributions to practical and applied sciences.

Impact and Influence 🌍

Prof. Hermenean’s influence extends beyond her research and teaching. Her roles in managing research councils and institutes highlight her ability to shape research strategies and educational programs. Her contributions have had a tangible impact on the advancement of biomedical sciences, particularly in the fields of histology, nanobiotechnology, and regenerative medicine.

Her work on phytomedicine and nanobiotechnology is particularly notable for its potential applications in developing new therapeutic approaches and improving existing medical treatments. Her patents and research projects reflect her commitment to translating scientific discoveries into practical solutions.

Legacy and Future Contributions 🔮

Prof. Hermenean’s legacy is marked by her dedication to advancing scientific knowledge and training the next generation of researchers. Her leadership in establishing and managing research infrastructures, such as the animal facility and microscopy labs at VGWU, demonstrates her commitment to fostering a supportive environment for cutting-edge research.

Looking ahead, Prof. Hermenean is poised to continue making significant contributions to her fields of expertise. Her ongoing research and collaborations are expected to yield further advancements in phytomedicine, nanobiotechnology, and regenerative medicine. Her role as a mentor and educator will also play a crucial part in shaping future research and development in these areas.

🎓Publication 

Chrysin-loaded calixarene-cyclodextrin ternary drug delivery system inhibits TGF-β and galectin-1 mediated pathways in diabetic liver

  • Authors   :Balta, C., Herman, H., Ciceu, A., … D’Amico, M., Hermenean, A..
  • Journal    :Biochemical Pharmacology
  • Year         :2024

Dexmedetomidine improves the circulatory dysfunction of the glymphatic system induced by sevoflurane through the PI3K/AKT/ΔFosB/AQP4 pathway in young mice

  • Authors   :Wang, S., Yu, X., Cheng, L., … Lu, Y., Wu, X..
  • Journal    :Cell Death and Disease
  • Year         :2024

Exploring In Vivo Pulmonary and Splenic Toxicity Profiles of Silicon Quantum Dots in Mice

  • Authors   :Cristian, R.-E., Balta, C., Herman, H., … Dinischiotu, A., Stan, M.S..
  • Journal    :Materials.
  • Year         :2024

Ketamine administration causes cognitive impairment by destroying the circulation function of the glymphatic system

Colloidal and Biological Characterization of Dual Drug-Loaded Smart Micellar Systems

  • Authors   :Herman, H., Rata, D.M., Cadinoiu, A.N., Atanase, L.I., Hermenean, A..
  • Journal    :Polymers
  • Year         :2024

Prof Dr. Abhijit Chaudhury |Antibiotic Resistance| Best Researcher Award

Published on by Top Pharmaceutical

Prof Dr. Abhijit Chaudhury|Antibiotic Resistance|Best Researcher Award|

Prof Dr. Abhijit Chaudhury at SV INstitute of Medical Sciences, India

PROFILE  

scopus

Orcid

Early Academic Pursuits 🎓

Dr. Abhijit Chaudhury’s journey into the field of microbiology began with a strong academic foundation. He earned his MBBS from the esteemed Medical College, Calcutta, where he developed a keen interest in the microscopic world and its implications on human health. His pursuit of medical education led him to the Institute of Medical Sciences (IMS), Banaras Hindu University (BHU), Varanasi, where he completed his MD. These early years of rigorous training equipped Dr. Chaudhury with the knowledge and skills necessary to excel in the field of microbiology, setting the stage for a distinguished career in academia and research.

Professional Endeavors and Teaching Experiences 🌍

Dr. Chaudhury’s professional journey is marked by a rich and diverse teaching career spanning multiple countries and institutions. As a Professor of Microbiology at Sri Venkateswara Institute of Medical Sciences and Sri Padmavathi Medical College for Women in Tirupati, he has played a pivotal role in shaping the minds of future medical professionals. His teaching experiences extend beyond India, having taught in Nepal, Mauritius, Oman, and the Netherlands Antilles. This international exposure has not only broadened his own perspectives but has also enriched the learning experiences of his students, who benefit from his global insights and expertise.

Contributions and Research Focus 🔬

Dr. Chaudhury’s contributions to the field of microbiology are significant and far-reaching. He has authored nearly 100 papers in indexed journals, showcasing his commitment to advancing scientific knowledge. His research primarily focuses on tropical parasitology, a field in which he is recognized as a Fellow of the Indian Academy of Tropical Parasitology (FIATP). His work has been instrumental in understanding and combating parasitic diseases that affect millions in tropical regions.

In addition to his research papers, Dr. Chaudhury has contributed seven book chapters published by renowned publishers such as Wiley and Springer. His role as Co-Editor of the “Textbook of Parasitic Zoonoses,” published by Springer Nature, further underscores his expertise and leadership in the field. This textbook serves as a critical resource for researchers and healthcare professionals dealing with parasitic infections transmitted from animals to humans.

Accolades and Recognition 🏆

Dr. Chaudhury’s expertise has not gone unrecognized. He has been an active participant in various national and state conferences, where he has presented his research and shared his knowledge through lectures. His work has also gained international recognition, with invitations to present papers at conferences in Europe, Canada, and the USA. These accolades highlight his status as a respected figure in the global scientific community.

His role as a reviewer of the Antibiotic Treatment Guidelines for the Government of West Bengal is a testament to his expertise and trustworthiness in the field. Furthermore, his contributions to the National Task Force on Curriculum Development for the Medical Lab Technology course have had a lasting impact on medical education in India.

Leadership and Community Impact 🤝

Dr. Chaudhury has also made significant contributions to professional organizations. As an executive member of the Indian Academy of Tropical Parasitology (IATP), he has been instrumental in promoting the study and control of parasitic diseases in India. His efforts led to the establishment of the Andhra Pradesh chapter of IATP in 2013, where he has continued to serve as a guiding force. In November 2022, he served as the President of the State Chapter Conference of IATP, further demonstrating his leadership and commitment to the field.

His tenure as the Chief Managing Editor of the “Tropical Parasitology” journal underscores his influence in academic publishing. Under his leadership, the journal flourished, providing a platform for researchers to publish their findings and contribute to the global understanding of parasitic diseases.

Impact and Influence 🌟

Dr. Chaudhury’s impact on the field of microbiology, particularly in tropical parasitology, is profound. His research has contributed to a better understanding of parasitic diseases, which disproportionately affect tropical regions. His work has not only advanced scientific knowledge but has also influenced public health policies, particularly in the development of treatment guidelines.

His influence extends to the many students he has mentored over the years, both in India and abroad. His dedication to teaching and research has inspired a new generation of microbiologists who are now contributing to the field in their own right.

Legacy and Future Contributions 🌱

As Dr. Chaudhury continues his work, his legacy is already taking shape. His contributions to research, education, and public health will have a lasting impact on the field of microbiology. The textbooks and research papers he has authored will continue to serve as valuable resources for future generations of scientists and healthcare professionals.

Looking to the future, Dr. Chaudhury is likely to remain a key figure in microbiology and tropical parasitology. His ongoing research and participation in international conferences suggest that he will continue to contribute valuable insights and advancements to the field. As he builds on his impressive body of work, Dr. Chaudhury’s legacy will be one of dedication, leadership, and a relentless pursuit of knowledge.

Conclusion 🌍

Dr. Abhijit Chaudhury’s career is a shining example of excellence in microbiology. From his early academic pursuits to his professional endeavors, his contributions to research, education, and public health have left an indelible mark on the field. His leadership and influence have shaped the study of tropical parasitology in India and beyond, ensuring that his legacy will endure for years to come.

🎓Publication 

In vitro activity of the newly approved antimicrobial agent Cefiderocol against Carbapenem resistant Gram negative clinical isolates

Molecular diversity of Mycobacterium tuberculosis isolates in Treatment-experienced Patients from Andhra Pradesh, India

Prevalence of histidine‑rich protein 2 deletion among the Plasmodium falciparum isolates from Kolkata

  • Authors   :Acharya, A., Saha, P., Chaudhury, A., Guha, S.K., Maji, A.K.L.
  • Journal    :Tropical Parasitology
  • Year         :2023

Molecular Characterization and Identification of Potential Inhibitors for ‘E’ Protein of Dengue Virus

  • Authors   :Racherla, R.G., Katari, S.K., Mohan, A., … Kante, M., Kalawat, U..
  • Journal    :Viruses
  • Year         :2022

Sir U.N. Brahmachari and his battle against Kala-Azar

  • Authors   :Saha, P., Chaudhury, A., Maji, A.K..
  • Journal    :Tropical Parasitology
  • Year         :2021

Dr.Long Pang |Oncology Pharmaceuticals| Best Researcher Award-1332

Published on by Top Pharmaceutical

Dr.Long Pang|Oncology Pharmaceuticals |Best Researcher Award|

Dr.Long Pang at Xi’an Medical University, China

PROFILE  

scopus

Early Academic Pursuits 📚

Long Pang was born in Gansu, China, where he developed an early passion for science and innovation. His academic journey began with a focus on veterinary science, where he pursued a Master of Science (M.S.) degree at Northwest Agricultural and Forestry University in Yangling, Shaanxi, China. Completing his M.S. in July 2012, Pang demonstrated an exceptional commitment to his studies and research in veterinary science, laying the groundwork for his future endeavors in animal biotechnology. In August 2012, he advanced his academic career by enrolling in a Ph.D. program at the same university. During his Ph.D. studies, he specialized in Animal Biotechnology, a field that encompasses the use of biotechnological tools for the improvement of animal health and productivity. He completed his Ph.D. in July 2016, marking the beginning of a promising career in biomedical research.

Professional Endeavors 🏢

After earning his Ph.D., Long Pang joined Xi’an Medical University as an Associate Professor in the School of Basic Medical Science. His professional career is distinguished by his innovative research in the areas of microfluidics and single-cell analysis. At Xi’an Medical University, Pang quickly established himself as a leading researcher, focusing on the development of microfluidic chips and their applications in single-cell analysis and organ-on-a-chip technology. His work has been instrumental in advancing the understanding of cellular mechanics and tumor microenvironments, contributing significantly to the fields of biomedical engineering and cancer research.

Contributions and Research Focus 🔬

Long Pang’s research primarily revolves around microfluidics-based single-cell analysis and organ-on-a-chip technologies. His work has led to the development of innovative microfluidic devices that allow for the manipulation and analysis of single cells in a highly controlled environment. These devices have broad applications in cancer research, particularly in studying tumor microenvironments and the behavior of cancer stem cells. One of his significant contributions includes the development of a microfluidic chip for glioma stem cell sorting and single-cell-derived tumor sphere assays. This research has provided valuable insights into the formation of tumor spheres and the role of the tumor microenvironment in cancer progression.

Pang has also been involved in projects aimed at integrating microfluidic platforms with other technologies to enhance the precision and efficiency of single-cell analysis. His research has been supported by several prestigious grants, including those from the National Science Foundation of China and the Fundamental Research Foundation of Xi’an Medical University. Notably, he has led projects such as the study of heterotypic single-cell-derived tumor-sphere formation using an integrated microfluidics platform, which has garnered significant attention and funding.

Accolades and Recognition 🏆

Long Pang’s contributions to the field of biomedical research have been widely recognized. His work has resulted in over 21 publications in high-impact journals, including TRAC-Trends in Analytical Chemistry, Analytical Chemistry, and Sensors & Actuators B: Chemical. He has also authored a chapter in the Handbook of Single-Cell Technologies, published by Springer, highlighting his expertise in digital microfluidics for single-cell manipulation and analysis. In addition to his publications, Pang has been granted two Chinese patents related to his innovations in microfluidic technology, further establishing his reputation as a leading researcher in his field.

Pang’s achievements have also been acknowledged through various editorial appointments. He has served as a Youth Editorial Board Member of Glioma and the E-Journal of Translational Medicine, where he has contributed to the advancement of research dissemination and knowledge sharing in the scientific community. His contributions to the academic community extend beyond research, as he is an active member of several professional organizations, including the Shaanxi Pharmacology Association, the Chinese Society of Micro-Nano Technology (CSMNT), and the Chinese Chemistry Society (CCS).

Impact and Influence 🌍

The impact of Long Pang’s research extends beyond academia. His work on microfluidic devices has the potential to revolutionize the way single-cell analysis is conducted, offering new tools for researchers and clinicians in the diagnosis and treatment of diseases, particularly cancer. His contributions to the development of organ-on-a-chip technology are also significant, providing a platform for more accurate and efficient drug testing, which could lead to more effective treatments for various diseases.

Pang’s research has influenced a new generation of scientists and engineers, inspiring them to explore the possibilities of microfluidics and its applications in biomedical research. His collaborations with other leading researchers and institutions, both in China and internationally, have further expanded the reach of his work, fostering innovation and knowledge exchange in the global scientific community.

Legacy and Future Contributions 🚀

Long Pang’s legacy in the field of biomedical research is characterized by his innovative approach to solving complex problems in cell biology and medicine. His contributions to the development of microfluidic technology and single-cell analysis tools have set new standards in the field, paving the way for future research and innovation. As he continues his work at Xi’an Medical University, Pang remains committed to advancing the frontiers of biomedical engineering, with a focus on developing new technologies that can improve human health and well-being.

Looking to the future, Long Pang’s ongoing research projects, such as the construction of a 3D microenvironment for single-cell level tumor cells, promise to yield further breakthroughs in our understanding of cancer and other diseases. His work is likely to continue to influence the field for years to come, as he mentors the next generation of researchers and contributes to the global effort to improve healthcare through technological innovation.

🎓Publication 

Tumor microenvironment-derived exosomes-assisted single-cell-derived tumor-sphere formation and drug-resistance by a microfluidic system

Construction of multiple concentration gradients for single-cell level drug screening

Droplets microfluidics platform—A tool for single cell research

Microfluidics-Based Single-Cell Research for Intercellular Interaction

Digital Microfluidics for Single Cell Manipulation and Analysis

  • Authors   :Pang, L., Ding, J., Fan, S.-K.
  • Journal    :Handbook of Single-Cell Technologies
  • Year         :2021

D. Mina Kiani |Endocrine Pharmacology| Best Researcher Award

Published on by Top Pharmaceutical

D. Mina Kiani|Endocrine Pharmacology |Best Researcher Award|

D. Mina Kiani at Arak university, Iran

PROFILE  

scopus

Early Academic Pursuits 🎓

Mina Kiani’s academic journey began with a deep passion for the biological sciences, particularly in understanding the intricate processes that govern cell biology and development. She pursued her Bachelor’s degree in Biology at a reputable university in Iran, where she developed a solid foundation in the life sciences. Eager to delve deeper into the complexities of human biology, she continued her education by obtaining a Master’s degree in Histology and Embryology from Razi University of Kermanshah. Her master’s thesis, which focused on the histological changes in embryonic development, showcased her keen interest in developmental biology and set the stage for her future research endeavors.

Driven by a desire to contribute to the scientific community, Mina Kiani pursued a Ph.D. in Cell Biology and Development at Arak University. During her doctoral studies, she embarked on a pioneering research project that explored the effects of the antidiabetic drug empagliflozin on the reproductive system of diabetic rats. This research was particularly significant as it addressed a previously unexplored area of study, highlighting her innovative approach to scientific research.

Professional Endeavors 🧪

After completing her Ph.D., Mina Kiani joined the faculty at Arak University as a lecturer, where she has since been dedicated to both teaching and research. Her role as an educator has allowed her to share her expertise in cell biology, histology, and embryology with the next generation of scientists. Kiani is highly regarded by her students for her ability to simplify complex concepts and her commitment to fostering a deep understanding of biological sciences.

In addition to her teaching responsibilities, Kiani has been actively involved in research. Her work primarily focuses on pharmacokinetics, endocrine pharmacology, and drug safety, with a particular interest in how various drugs affect reproductive health. Her research has led to significant findings in the field, particularly concerning the impact of empagliflozin on testicular tissue and sperm parameters in diabetic rats.

Contributions and Research Focus 🔬

Mina Kiani’s contributions to the field of pharmacology and reproductive biology are both profound and innovative. Her research on empagliflozin, a relatively new antidiabetic drug, has been groundbreaking. Recognizing the increasing prevalence of type 2 diabetes among young men, Kiani sought to understand how this drug affects male reproductive health—a critical area that had not been previously studied.

Her research revealed that empagliflozin has antioxidant, anti-apoptotic, and anti-inflammatory effects on the testicular tissue of diabetic rats. These findings are crucial as they suggest that the drug may mitigate some of the harmful effects of diabetes on male fertility, potentially offering new therapeutic avenues for patients. Kiani’s work has been published in the prestigious journal Biochemical Pharmacology, where her study, “Empagliflozin reduces the adverse effects of diabetes mellitus on testicular tissue in type 2 diabetic Rats: A stereological and biochemical study,” has garnered attention for its scientific rigor and clinical relevance.

Accolades and Recognition 🏆

Mina Kiani’s work has not gone unnoticed in the scientific community. Her innovative research on the effects of empagliflozin has earned her recognition as a leading researcher in her field. The publication of her study in a high-impact journal is a testament to the quality and significance of her research. Moreover, her dedication to teaching and her ability to inspire students have made her a respected figure at Arak University.

While Kiani has not yet received formal awards for her work, the impact of her research is evident in the scientific community’s response to her publications. Her study on empagliflozin has been cited by other researchers, further validating the importance of her findings.

Impact and Influence 🌍

Mina Kiani’s research has the potential to influence clinical practices related to the treatment of diabetes in young men. By shedding light on the effects of empagliflozin on reproductive health, her work could lead to more informed decisions regarding the prescription of this drug to diabetic patients, particularly those concerned with fertility. Additionally, her research contributes to a broader understanding of the relationship between diabetes and reproductive health, an area that is becoming increasingly important as the prevalence of diabetes continues to rise globally.

As an educator, Kiani has also made a significant impact on her students, many of whom have gone on to pursue careers in the biological sciences. Her ability to connect with students and her dedication to their academic and professional development have helped shape the next generation of researchers and healthcare professionals.

Legacy and Future Contributions 🌟

Mina Kiani’s legacy is one of innovation, dedication, and a commitment to advancing our understanding of pharmacology and reproductive health. Her pioneering research on empagliflozin has opened new avenues for exploration and has the potential to improve the lives of countless individuals living with diabetes. As she continues her research, Kiani is likely to make further contributions to the field, particularly in understanding how other antidiabetic drugs affect reproductive health.

Looking ahead, Kiani is poised to continue her work at the intersection of pharmacology and reproductive biology. She plans to expand her research to include studies on the long-term effects of empagliflozin and other antidiabetic drugs on reproductive health. Additionally, she aims to collaborate with other researchers and institutions to further explore the complex relationships between diabetes, pharmacology, and fertility.

🎓Publication 

Empagliflozin reduces the adverse effects of diabetes mellitus on testicular tissue in type 2 diabetic Rats: A stereological and biochemical study

  • Authors   :Kiani, M., Soleimani Mehranjani, M., Ali Shariatzadeh, M.
  • Journal    :Biochemical Pharmacology
  • Year         :2024

Sildenafil citrate ameliorates the adverse effects of cryopreservation on sperm quality in asthenozoospermic men

  • Authors   :Kohzadi, R., Cheraghi, E., Mehranjani, M.S., Shariatzadeh, M.
  • Journal    :Healthcare Materials
  • Year         :2024

Seamless Integration of Rapid Separation and Ultrasensitive Detection for Complex Biological Samples Using Multistage Annular Functionalized Carbon Nanotube Arrays

  • Authors   :Lihuang Li; Jialing Zhang; Zhengqi Jiao; Xi Zhou; Lei Ren; Miao Wang.
  • Journal    :Cryobiology
  • Year         :2023

The effect of platelet lysate on mouse ovarian structure, function and epigenetic modifications after autotransplantation

  • Authors   :Sanamiri, K., Soleimani Mehranjani, M., Shahhoseini, M., Shariatzadeh, S.M.A.
  • Journal    :Reproductive BioMedicine Online
  • Year         :2023

The therapeutic effect of co-administration of pentoxifylline and zinc in men with idiopathic infertility